Energy News / Shareholders Foundation, Inc.

NASDAQ: RLMD Investor Notice: Investigation over Possible Wrongdoing at Relmada Therapeutics, Inc.

Via: ReleaseWire

Updated 10:25 AM CST, Fri, February 14,2020

An investigation on behalf of investors in Relmada Therapeutics, Inc. (NASDAQ: RLMD) shares over potential wrongdoing at Relmada Therapeutics, Inc. was announced and NASDAQ: RLMD stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 02/14/2020 -- An investigation on behalf of investors in shares of Relmada Therapeutics, Inc. (NASDAQ: RLMD) was announced over potential breaches of fiduciary duties by certain officers and directors at Relmada Therapeutics, Inc.

Investors who purchased shares of Relmada Therapeutics, Inc. (NASDAQ: RLMD) and currently hold any of those NASDAQ: RLMD shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Relmada Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.

New York based Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Relmada Therapeutics, Inc. reported that its Net Loss increased from $6.28 million for the 12 months period that ended on June 30, 2017 to $17.31 million for the 12 months period that ended on June 30, 2019.

Shares of Relmada Therapeutics, Inc. (NASDAQ: RLMD) closed on February 6, 2020 at $41.99 per share.

Those who purchased shares of Relmada Therapeutics, Inc. (NASDAQ: RLMD), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaq-rlmd-investor-notice-investigation-over-possible-wrongdoing-at-relmada-therapeutics-inc-1276550.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com